AstraZeneca PLC (LON:AZN)
12,210
+306 (2.57%)
Sep 3, 2025, 7:03 PM BST
AstraZeneca Market Cap
AstraZeneca has a market cap or net worth of 189.34 billion as of September 3, 2025. Its market cap has decreased by -6.05% in one year.
Market Cap
189.34B
Enterprise Value
208.26B
Revenue
41.24B
Ranking
n/a
PE Ratio
31.51
Stock Price
12,210.00
Market Cap Chart
Since May 28, 1993, AstraZeneca's market cap has increased from 4.55B to 189.34B, an increase of 4,060.94%. That is a compound annual growth rate of 12.24%.
Market Cap History
Date | Market Cap | % Change |
---|---|---|
Sep 2, 2025 | 184.59B | 13.75% |
Dec 31, 2024 | 162.29B | -1.22% |
Dec 29, 2023 | 164.29B | -5.48% |
Dec 30, 2022 | 173.83B | 29.30% |
Dec 31, 2021 | 134.44B | 39.83% |
Dec 31, 2020 | 96.14B | -3.67% |
Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
Dec 31, 2015 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
Company | Market Cap |
---|---|
GSK plc | 59.11B |
Haleon | 32.53B |
Smith & Nephew | 11.98B |
ConvaTec Group | 4.80B |
Hikma Pharmaceuticals | 3.86B |
HUTCHMED (China) | 1.95B |
Genus | 1.64B |
Oxford Nanopore Technologies | 1.57B |